Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Company dna crucell holland bv
no operation time available
1 office
active in Legal Services

We have observed 8 EP applications Richard Abraham Verhage has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after May 28, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12790771

HETEROLOGOUS PRIME-BOOST IMMUNIZATION USING MEASLES VIRUS-BASED VACCINES

IPC classification:
A61K 39/155, A61K 39/165, A61K 39/235
Applicant:
Crucell Holland B.V.
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Multiple attorneys, Crucell Holland B.V.
Status:
EXAMINATION IN PROGRESS
EP13708445

BATCHES OF RECOMBINANT ADENOVIRUS WITH ALTERED TERMINAL ENDS

IPC classification:
C12N 7/00, C12N 7/02, C12N 15/86, C12N 15/861
Applicant:
Crucell Holland B.V.
Agent:
Multiple attorneys, Crucell Holland B.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11757867

THERAPEUTIC VACCINATION AGAINST ACTIVE TUBERCULOSIS

IPC classification:
A61K 39/04, A61P 31/06, C07K 14/35
Applicant:
Crucell Holland B.V.
Agent:
Multiple attorneys, Crucell Holland B.V.
Agent:
Multiple attorneys, Janssen Vaccines & Prevention B.V.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13821463

HUMAN SERUM ALBUMIN BINDING COMPOUNDS AND FUSION PROTEINS THEREOF

IPC classification:
C07K 14/47, C07K 14/765, C12N 1/15, C12N 1/21, C12N 5/10
Applicant:
Covagen AG
Agent:
Richard Abraham Verhage, Crucell Holland B.V.
Agent:
Richard Abraham Verhage, Janssen Vaccines & Prevention B.V.
Status:
EXAMINATION IN PROGRESS
EP14710220

NOVEL BISPECIFIC BINDING MOLECULES WITH ANTITUMORAL ACTIVITY

IPC classification:
C07K 14/47, C07K 16/28, C07K 16/46
Applicant:
Covagen AG
Agent:
Richard Abraham Verhage, Crucell Holland B.V.
Agent:
Richard Abraham Verhage, Janssen Vaccines & Prevention B.V.
Status:
EXAMINATION IN PROGRESS
EP12703101

PNEUMATIC ALTERNATING PRESSURE MEMBRANE CELL SEPARATION SYSTEM

IPC classification:
B01D 61/20, B01D 61/22, B01D 65/02, B01D 65/08
Applicant:
Crucell Holland B.V.
Agent:
Multiple attorneys, Crucell Holland B.V.
Agent:
Multiple attorneys, Janssen Vaccines & Prevention B.V.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11849865

ADENOVIRUS SEROTYPE 26 AND SEROTYPE 35 FILOVIRUS VACCINES

IPC classification:
A61K 39/00, A61K 39/12, A61K 39/235, C07K 14/005, C12N 7/01
Applicant:
Crucell Holland B.V.
Agent:
Multiple attorneys, Crucell Holland B.V.
Agent:
Multiple attorneys, Janssen Vaccines & Prevention B.V.
Status:
The patent has been granted
EP15791556

THERAPEUTIC HPV16 VACCINES

IPC classification:
A61K 39/00, A61K 39/12, C07K 14/005, C07K 14/025
Agent:
Richard Abraham Verhage, Crucell Holland B.V.
Agent:
Richard Abraham Verhage, Janssen Vaccines & Prevention B.V.
Status:
Request for examination was made

Please Sign in to use this feature